Artificial heart and assist devices: Directions, needs, costs, societal and ethical issues

R. L. van Citters, C. B. Bauer, L. K. Christopherson, R. C. Eberhart, D. M. Eddy, R. L. Frye, A. R. Jonsen, K. H. Keller, R. J. Levine, D. C. McGoon

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

A working Group appointed by the Director of the National Heart, Lung, and Blood Institute (NHBLI) has reviewed the current status of mechanical circulatory support systems (MCSS), and has examined the potential need for such devices, their cost, and certain societal and ethical issues related to their use. A retrospective analysis of needs was carried out within a defined population. The resulting projection of 17,000 - 35,000 cases annually, in patients below age 70, falls within the general range of earlier estimates, but is highly sensitive to many variables. In the absence of an actual base of data and experience with MCSS, projection of costs and prognoses was carried out using explicit sets of assumptions. The total cost of a left ventricular assist device, its implantation and maintenance for a projected average of 4 1/2 years of survival might be approximately $ 150,000 (in 1983 dollars). The gross annual cost to society could fall in the range of $ 2.5 - $ 5 billion. Ethical issues associated with use of the artificial heart are not unique. For individual patients these relate primarily to risk-benefit, informed consent, patient selection, and privacy. However, for society as a whole, the larger concern relates to the distribution of national resources.

Original languageEnglish (US)
Pages (from-to)375-415
Number of pages41
JournalArtificial Organs
Volume9
Issue number4
StatePublished - 1985

Fingerprint

Artificial heart
Artificial Heart
Heart-Assist Devices
Ethics
Costs and Cost Analysis
Cardiovascular System
Costs
Left ventricular assist devices
National Heart, Lung, and Blood Institute (U.S.)
Projection systems
Privacy
Informed Consent
Patient Selection
Blood
Maintenance
Equipment and Supplies
Survival
Direction compound
Population

ASJC Scopus subject areas

  • Biophysics

Cite this

van Citters, R. L., Bauer, C. B., Christopherson, L. K., Eberhart, R. C., Eddy, D. M., Frye, R. L., ... McGoon, D. C. (1985). Artificial heart and assist devices: Directions, needs, costs, societal and ethical issues. Artificial Organs, 9(4), 375-415.

Artificial heart and assist devices : Directions, needs, costs, societal and ethical issues. / van Citters, R. L.; Bauer, C. B.; Christopherson, L. K.; Eberhart, R. C.; Eddy, D. M.; Frye, R. L.; Jonsen, A. R.; Keller, K. H.; Levine, R. J.; McGoon, D. C.

In: Artificial Organs, Vol. 9, No. 4, 1985, p. 375-415.

Research output: Contribution to journalArticle

van Citters, RL, Bauer, CB, Christopherson, LK, Eberhart, RC, Eddy, DM, Frye, RL, Jonsen, AR, Keller, KH, Levine, RJ & McGoon, DC 1985, 'Artificial heart and assist devices: Directions, needs, costs, societal and ethical issues', Artificial Organs, vol. 9, no. 4, pp. 375-415.
van Citters RL, Bauer CB, Christopherson LK, Eberhart RC, Eddy DM, Frye RL et al. Artificial heart and assist devices: Directions, needs, costs, societal and ethical issues. Artificial Organs. 1985;9(4):375-415.
van Citters, R. L. ; Bauer, C. B. ; Christopherson, L. K. ; Eberhart, R. C. ; Eddy, D. M. ; Frye, R. L. ; Jonsen, A. R. ; Keller, K. H. ; Levine, R. J. ; McGoon, D. C. / Artificial heart and assist devices : Directions, needs, costs, societal and ethical issues. In: Artificial Organs. 1985 ; Vol. 9, No. 4. pp. 375-415.
@article{9438abe2bc1146cb90900dbdf68bd032,
title = "Artificial heart and assist devices: Directions, needs, costs, societal and ethical issues",
abstract = "A working Group appointed by the Director of the National Heart, Lung, and Blood Institute (NHBLI) has reviewed the current status of mechanical circulatory support systems (MCSS), and has examined the potential need for such devices, their cost, and certain societal and ethical issues related to their use. A retrospective analysis of needs was carried out within a defined population. The resulting projection of 17,000 - 35,000 cases annually, in patients below age 70, falls within the general range of earlier estimates, but is highly sensitive to many variables. In the absence of an actual base of data and experience with MCSS, projection of costs and prognoses was carried out using explicit sets of assumptions. The total cost of a left ventricular assist device, its implantation and maintenance for a projected average of 4 1/2 years of survival might be approximately $ 150,000 (in 1983 dollars). The gross annual cost to society could fall in the range of $ 2.5 - $ 5 billion. Ethical issues associated with use of the artificial heart are not unique. For individual patients these relate primarily to risk-benefit, informed consent, patient selection, and privacy. However, for society as a whole, the larger concern relates to the distribution of national resources.",
author = "{van Citters}, {R. L.} and Bauer, {C. B.} and Christopherson, {L. K.} and Eberhart, {R. C.} and Eddy, {D. M.} and Frye, {R. L.} and Jonsen, {A. R.} and Keller, {K. H.} and Levine, {R. J.} and McGoon, {D. C.}",
year = "1985",
language = "English (US)",
volume = "9",
pages = "375--415",
journal = "Artificial Organs",
issn = "0160-564X",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Artificial heart and assist devices

T2 - Directions, needs, costs, societal and ethical issues

AU - van Citters, R. L.

AU - Bauer, C. B.

AU - Christopherson, L. K.

AU - Eberhart, R. C.

AU - Eddy, D. M.

AU - Frye, R. L.

AU - Jonsen, A. R.

AU - Keller, K. H.

AU - Levine, R. J.

AU - McGoon, D. C.

PY - 1985

Y1 - 1985

N2 - A working Group appointed by the Director of the National Heart, Lung, and Blood Institute (NHBLI) has reviewed the current status of mechanical circulatory support systems (MCSS), and has examined the potential need for such devices, their cost, and certain societal and ethical issues related to their use. A retrospective analysis of needs was carried out within a defined population. The resulting projection of 17,000 - 35,000 cases annually, in patients below age 70, falls within the general range of earlier estimates, but is highly sensitive to many variables. In the absence of an actual base of data and experience with MCSS, projection of costs and prognoses was carried out using explicit sets of assumptions. The total cost of a left ventricular assist device, its implantation and maintenance for a projected average of 4 1/2 years of survival might be approximately $ 150,000 (in 1983 dollars). The gross annual cost to society could fall in the range of $ 2.5 - $ 5 billion. Ethical issues associated with use of the artificial heart are not unique. For individual patients these relate primarily to risk-benefit, informed consent, patient selection, and privacy. However, for society as a whole, the larger concern relates to the distribution of national resources.

AB - A working Group appointed by the Director of the National Heart, Lung, and Blood Institute (NHBLI) has reviewed the current status of mechanical circulatory support systems (MCSS), and has examined the potential need for such devices, their cost, and certain societal and ethical issues related to their use. A retrospective analysis of needs was carried out within a defined population. The resulting projection of 17,000 - 35,000 cases annually, in patients below age 70, falls within the general range of earlier estimates, but is highly sensitive to many variables. In the absence of an actual base of data and experience with MCSS, projection of costs and prognoses was carried out using explicit sets of assumptions. The total cost of a left ventricular assist device, its implantation and maintenance for a projected average of 4 1/2 years of survival might be approximately $ 150,000 (in 1983 dollars). The gross annual cost to society could fall in the range of $ 2.5 - $ 5 billion. Ethical issues associated with use of the artificial heart are not unique. For individual patients these relate primarily to risk-benefit, informed consent, patient selection, and privacy. However, for society as a whole, the larger concern relates to the distribution of national resources.

UR - http://www.scopus.com/inward/record.url?scp=0022340342&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022340342&partnerID=8YFLogxK

M3 - Article

C2 - 3910005

AN - SCOPUS:0022340342

VL - 9

SP - 375

EP - 415

JO - Artificial Organs

JF - Artificial Organs

SN - 0160-564X

IS - 4

ER -